Reduced liver damage and fibrosis with combined SCD Probiotics and intermittent fasting in aged rat
Journal of Cellular and Molecular Medicine · 2024-01 · 28 (1)
DOI: 10.1111/jcmm.18014 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, online erschienen am 28.10.2023. Verfasst von Hikmet Taner Teker und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Biology and Genetics, Ankara Medipol University, Ankara, Turkey. Hauptthemen laut MEDLINE: Probiotics, Liver Diseases. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
This study aimed to examine the impact of SCD Probiotics supplementation on liver biomolecule content and histological changes during a 30‐day intermittent fasting (IF) program in 24‐month‐old male Sprague–Dawley rats. Rats underwent 18‐h daily fasting and received 1 × 10 8 CFU of SCD Probiotics daily. Liver tissue biomolecules were analysed using FTIR Spectroscopy, LDA, and SVM techniques, while histopathological evaluations used Haematoxylin and eosin and Masson trichrome‐stained tissues. Blood samples were collected for biochemical analysis. Gross alterations in the quantity of biomolecules were observed with individual or combined treatments. LDA and SVM analyses demonstrated a high accuracy in differentiating control and treated groups. The combination treatments led to the most significant reduction in cholesterol ester (1740 cm −1 ) and improved protein phosphorylation (A 1239 /A 2955 and A 1080 /A 1545 ) and carbonylation (A 1740 /A 1545 ). Individually, IF and SCD Probiotics were more effective in enhancing membrane dynamics (Bw 2922 /Bw 2955 ). In treated groups, histological evaluations showed decreased hepatocyte degeneration, lymphocyticinfiltration, steatosis and fibrosis. Serum ALP, LDH and albumin levels significantly increased in the SCD Probiotics and combined treatment groups. This study offers valuable insights into the potential mechanisms behind the beneficial effects of IF and SCD Probiotics on liver biomolecule content, contributing to the development of personalized nutrition and health strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medical Biology and Genetics, Ankara Medipol University, Ankara, Turkey.
- Department of Molecular Biology and Genetics, Muş Alparslan University, Muş, Turkey.
- Department of Food Quality Control and Analysis, Muş Alparslan University, Muş, Turkey.
- Department of Histology and Embryology, Van Yuzuncu Yil University, Van, Turkey.
- Department of Bioengineering, Bilecik Şeyh Edebali University, Bilecik, Turkey.
- Department of Medical Biochemistry, Yüksek İhtisas University, Ankara, Turkey.
ORCID-Profile: Taha Ceylani, Rafig Gurbanov
Zitieren
APA
Teker, H. T., Ceylani, T., Keskin, S., Samgane, G., Baba, B., Acıkgoz, E., & Gurbanov, R. (2024). Reduced liver damage and fibrosis with combined SCD Probiotics and intermittent fasting in aged rat. Journal of Cellular and Molecular Medicine, 28(1). https://doi.org/10.1111/jcmm.18014
Vancouver
Teker HT, Ceylani T, Keskin S, Samgane G, Baba B, Acıkgoz E, et al. Reduced liver damage and fibrosis with combined SCD Probiotics and intermittent fasting in aged rat. Journal of Cellular and Molecular Medicine. 2024;28(1). doi:10.1111/jcmm.18014
BibTeX
@article{Teker2024,
author = {Teker, Hikmet Taner and Ceylani, Taha and Keskin, Seda and Samgane, Gizem and Baba, Burcu and Acıkgoz, Eda and Gurbanov, Rafig},
title = {Reduced liver damage and fibrosis with combined SCD Probiotics and intermittent fasting in aged rat},
journal = {Journal of Cellular and Molecular Medicine},
year = {2024},
volume = {28},
number = {1},
doi = {10.1111/jcmm.18014}
}
EUVIMED